Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01399151 · ClinicalTrials.gov registry record · NA

Assessment of Vitamin D Supplementation and Immune Function

A NA study, sponsored by USDA, Western Human Nutrition Research Center.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT01399151 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01399151, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

Hypothesis: Volunteers with vitamin D insufficiency (serum 25(OH)D 25-50 nmol/L) given intermediate or high dose vitamin D supplements (2,000 or 5,000 IU per day) will have increased production of anti-bacterial peptides and interleukin-1, decreased production of other pro-inflammatory cytokines, increased production of regulatory cytokines and an enhanced T- and B-cell response to a tetanus vaccine compared to vitamin D insufficient subjects given low dose vitamin D supplements (400 IU per day).

Interventions

  • DIETARY_SUPPLEMENT Vitamin D - Treatment 1
  • DIETARY_SUPPLEMENT Vitamin D - Treatment 2
  • DIETARY_SUPPLEMENT Vitamin D - Treatment 3

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2011-01
Est. Completion 2014-04
Phase NA

What the Registry Record Tells You About NCT01399151

The ClinicalTrials.gov registry entry for NCT01399151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA, Western Human Nutrition Research Center, which has 47 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Vitamin D - Treatment 1 is the first listed.

NCT01399151 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01399151 about?

NCT01399151 is a clinical study titled "Assessment of Vitamin D Supplementation and Immune Function". Hypothesis: Volunteers with vitamin D insufficiency (serum 25(OH)D 25-50 nmol/L) given intermediate or high dose vitamin D supplements (2,000 or 5,000 IU per day) will have increased production of anti-bacterial peptides and interleukin-1, decreased production of other pro-inflammatory cytokines, i...

What is the current status of trial NCT01399151?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2011-01. Estimated completion is 2014-04.

What interventions are being tested in trial NCT01399151?

The interventions under investigation include: Vitamin D - Treatment 1 (DIETARY_SUPPLEMENT), Vitamin D - Treatment 2 (DIETARY_SUPPLEMENT), Vitamin D - Treatment 3 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01399151?

This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.